Metabolic activity and clinical features of primary ganglioneuromas

Cancer

Volumn 91, Issue 10, 2001, Pages 1905-1913

  Geoerger, Birgit ^a   Hero, Barbara ^b   Harms, Dieter ^a   Grebe, Jochen ^c   Scheidhauer, Klemens ^c   Berthold, Frank ^c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CATECHOLAMINE;

ADOLESCENT; ADULT; ARTICLE; CANCER SCINTISCANNING; CATECHOLAMINE BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; GANGLIONEUROMA; HUMAN; LYMPH NODE METASTASIS; MALE; NEUROBLASTOMA; PRIORITY JOURNAL;

3-IODOBENZYLGUANIDINE; ADOLESCENT; ADULT; CATECHOLAMINES; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GANGLIONEUROMA; HUMANS; IODINE RADIOISOTOPES; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0035873092     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010515)91:10<1905::AID-CNCR1213>3.0.CO;2-4     Document Type: Article

References (28)

1. Role of ploidy, chromosome 1p, and schwann cells in the maturation of neuroblastoma
2. Ganglioneuroma - Morphology and prognosis. Report from the Kiel Pediatric Tumor Registry
3. Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas
4. Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology Group
5. Cervical ganglioneuroma: A case report and review of the literature
6. Scintigraphy of a neuroblastoma with 1-131 metaiodobenzylguanididine
7. 131I]iodobenzylguanidine
8. Iodine-131 metaiodobenzylguanididine scintigraphy for the location of neuroblastoma: Preliminary experiences in ten cases
9. I-131 metaiodobenzylguanidine: Diagnostic use in neuroblastoma patients in relapse
10. Visualization of a ganglioneuroma by means of scintigraphy with 131-I-MIBG
11. Functionally active ganglioneuroma with increased plasma and urinary catecholamines and positive iodine 131-meta-iodobenzylguanidine scintigraphy
12. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging patients with neuroblastoma
13. Clinical manifestations of ganglioneuroma
14. Mediastinal ganglioneuroma with the secretive activity of catecholamines, visualized by 131-I-MIBG scintigraphy
15. Visualizacion de un ganglioneuroma mediante gammagrafia con 131-I-MIBG
16. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment
17. Mass fragmentographic determination of homovanillic and 4-hydroxy-3-methoxy mandelic acids in 50 microliter plasma
18. Effect of age on homovanillic and 4-hydroxy-3-methoxymandelic acid levels in plasma
19. The current contribution of molecular factors to risk estimation in neuroblastoma patients
20. Neuroblastom
21. Catecholamine metabolites in ganglioneuroma
22. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG)
23. Quantitative study of radioiodinated metaiodobenzylguanadine uptake in children with neuroblastoma: Correlation with tumor histopathology
24. Regression and progression in neuroblastoma: Does genetics predict tumour behaviour?
25. Maturation of tumor of the sympathetic nervous system
26. Terminology and morphologic criteria of neuroblastic tumors
27. The International Neuroblastoma Pathology Classification (the Shimada system)